A list of comments provided by BIOMARKABLE or the founder to studies and/or publications.
* 2019, February 4 – Blood Test Granted Breakthrough Status, To Be Tested in Trial
* 2012, May 30 – Optimizing CSF Aβ42 ELISA for Trials and Regulatory Approval